Efficacy of Antiplatelet Therapy in Myeloproliferative Diseases in Relation to Immature Platelets and Thrombosis

Key Points

• The study aims to explore the role of immature platelets in thrombotic complications among patients with myeloproliferative diseases and the efficacy of antiplatelet therapy.
• Assessment of thrombotic complications using impedance aggregometry
• Evaluation of the ASPItest for measuring thrombotic risk
• Analysis of immature platelet counts relative to thrombotic events
• Thrombotic complications are influenced by factors beyond impedance aggregometry.
• The ASPItest does not provide an adequate assessment of thrombotic risk in myeloproliferative diseases.